Open access
Jan 2026
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies
ABSTRACT The continuous emergence of variants of concern (VoCs) represents a significant challenge to effectively control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although FDA-approved vaccines and antivirals have been successfully developed and implemented for the prophylactic and therapeutic inte...
Esteban M. Castro, Ramya S. Barre, C. Ye et al.
· bioRxiv · 0 citations